Granules India Limited (GRANULES) secures Sole First-to-File status for its ANDA for Sodium Oxybate Extended-Release for Oral Suspension.
Granules India Limited (GRANULES) announced its USFDA EIR for Chantilly Facility with a Voluntary Action Indicated (VAI) classification.
